Weigh Thrombolytic Pros and Cons for Submassive Pulmonary Embolism

We're getting questions about using SYSTEMIC thrombolytics to treat "submassive," or intermediate-risk, pulmonary embolism (PE).

We know to give a systemic thrombolytic for most hemodynamically unstable, or "massive," PE patients...and to hold off for mild PEs.

But those in the middle are trickier. "Submassive" PE patients have systolic BP above 90 mmHg but right ventricular dysfunction on CT or echo...or elevated troponins or BNP.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals